Lv1
50 积分 2024-08-18 加入
Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation
1个月前
已完结
25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages
2个月前
已完结
Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1
2个月前
已完结
A Three-In-One Assembled Nanoparticle Containing Peptide-Radio-Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer-Immunity Cycle to Trigger Antitumor Immune Response
2个月前
已完结
Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles
2个月前
已完结
A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy
2个月前
已完结
Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy
2个月前
已完结
Brain targeted biomimetic siRNA nanoparticles for drug resistance glioblastoma treatment
2个月前
已完结
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed CellDeath-1/Programmed Cell Death–Ligand 1 Interaction as Potential AnticancerAgents
2个月前
已完结
[68Ga]Ga-AUNP-12 PET imaging to assess the PD-L1 status in preclinical and first-in-human study
2个月前
已完结
皖公网安备34019202002308
